D-Wave Quantum Inc. has disclosed a significant stock transaction involving its director, Krysler P. Kevan. The recent filing reveals that Kevan acquired 15,054 unvested restricted stock units (RSUs) on August 13, 2026. This acquisition may indicate a strong belief in the company's potential for growth and success.
The acquisition of RSUs is often seen as a positive sign, as it aligns the interests of the director with those of the shareholders. The vesting schedule for these units indicates that 8,363 RSUs will vest in three equal annual installments starting on August 13, 2027, while 6,691 RSUs will vest on May 31, 2027, contingent on Kevan's continued service with D-Wave.
Background
D-Wave Quantum Inc. operates within the computer processing and data preparation sector, classified under the SIC code 7374. The company trades on the Nasdaq under the ticker symbol QBTS. D-Wave is known for its innovative approaches to quantum computing, which positions it uniquely in the technology landscape.
What the Filing Says
The SEC filing, dated October 30, 2026, details the acquisition of 15,054 RSUs by Krysler P. Kevan. It states, "Represents 15,054 unvested restricted stock units (RSUs), each RSU representing the right to receive one share of Common Stock of the Issuer." This transaction reflects a strategic move by a key company leader.
Impact
This stock acquisition may impact D-Wave's stakeholders, including its employees, investors, and the broader market. The confidence expressed by a director acquiring significant equity could bolster investor sentiment and attract further interest in D-Wave's stock. Additionally, it may encourage other executives to align their interests with the company's performance.
What's Next
The filing does not say what happens next.
Read Next
Saba Capital Management Acquires Additional Shares of ECF
National Bank Holdings board member sells 4,000 shares
Saba Capital Management increases stake in Gabelli Healthcare
Kell Sean Davis sells over 21,000 shares of Porch Group, Inc.
Porch Group CFO Shawn Tabak Sells 30,000 Shares of Stock
Lifecore Biomedical announces merger with Lifecore Inc.







